Investors

Financials & Filings

Document Details

Form
Filing Date
Mar 13, 2026
Document Date
Mar 12, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xenon Pharmaceuticals Inc.
Issuer
Xenon Pharmaceuticals Inc.
Filer
MORTIMER IAN

Investor inquiries

Tucker Kelly 
Chief Financial Officer
investors@xenon-pharma.com
 

Email alerts

Sign up here to receive email alerts from Xenon Pharmaceuticals